siRNA-Mediated Knockdown of the mTOR Inhibitor RTP801 Promotes Retinal Ganglion Cell Survival and Axon Elongation by Direct and Indirect Mechanisms
Author(s) -
Peter Morgan-Warren,
Jenna O'Neill,
Felicity de Cogan,
Igor Spivak,
Hagit Ashush,
Hagar Kalinski,
Zubair Ahmed,
Martin Berry,
Elena Feinstein,
Robert A. H. Scott,
Ann Logan
Publication year - 2016
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.15-17511
Subject(s) - neurite , retinal ganglion cell , neuroprotection , axon , microbiology and biotechnology , pi3k/akt/mtor pathway , gene knockdown , retina , chemistry , gap 43 protein , biology , neuroscience , signal transduction , cell culture , immunology , biochemistry , in vitro , genetics , immunohistochemistry
To investigate, using in vivo and in vitro models, retinal ganglion cell (RGC) neuroprotective and axon regenerative effects and underlying mechanisms of siRTP801, a translatable small-interfering RNA (siRNA) targeting the mTOR negative regulator RTP801.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom